STERIS plc (STE) Insider Transactions
Explore official ownership filings, with every record linked to its source.
STE · STERIS plc
How to read this data ↗View six-calendar-month insider history →
Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-11-11Filed 2026-11-12 | Burton Karen LOfficer · Sr. Vice Pres., CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F3 | M Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,880D | 0 | Direct | Form 4 ↗0001628280-26-073444 |
| 2026-11-11Filed 2026-11-12 | Burton Karen LOfficer · Sr. Vice Pres., CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F1, F2 | S Sale (market/private)Ordinary Shares · Non-derivative | 5,880D | 255.62 | Direct | Form 4 ↗0001628280-26-073444 |
| 2026-11-11Filed 2026-11-12 | Burton Karen LOfficer · Sr. Vice Pres., CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: | M Exercise / conversionOrdinary Shares · Non-derivative | 5,880A | 147.05 | Direct | Form 4 ↗0001628280-26-073444 |
| 2026-11-10Filed 2026-11-12 | Sohi MohsenDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F3 | M Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,893D | 0 | Direct | Form 4 ↗0001628280-26-073442 |
| 2026-11-10Filed 2026-11-12 | Sohi MohsenDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F2 | S Sale (market/private)Ordinary Shares · Non-derivative | 1,665D | 253.9 | Direct | Form 4 ↗0001628280-26-073442 |
| 2026-11-10Filed 2026-11-12 | Sohi MohsenDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F1 | S Sale (market/private)Ordinary Shares · Non-derivative | 3,228D | 252.87 | Direct | Form 4 ↗0001628280-26-073442 |
| 2026-11-10Filed 2026-11-12 | Sohi MohsenDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: | M Exercise / conversionOrdinary Shares · Non-derivative | 4,893A | 114.74 | Direct | Form 4 ↗0001628280-26-073442 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.